Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
BMC Pulm Med ; 24(1): 441, 2024 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-39251951

RESUMO

BACKGROUND: To explore the associations of computed tomography (CT) image features with the serum cryptococcal antigen (CrAg) titers measured by the lateral flow assay (LFA) in localized pulmonary cryptococcosis patients. METHODS: A retrospective analysis of patients with pathologically confirmed pulmonary cryptococcosis admitted to the First Affiliated Hospital of Xiamen University from January 2016 to December 2022 was performed. Clinical data, CT results, serum CrAg-LFA test results, and follow-up data were collected and analyzed. RESULTS: A total of 107 patients with localized pulmonary cryptococcosis were included, of which 31 had a single lesion in chest CT and the other 76 had multiple lesions. The positivity rate was (94.74% vs 64.52%) and titers of serum CrAg-LFA (1.77 ± 0.87 vs 0.91 ± 0.98) in the multiple lesion group were higher than those in the single lesion group, respectively. Multivariate linear regression analysis showed that the serum CrAg titers were positively associated with the number of lesions (ß, 0.08; 95% CI, 0.05 to 0.12) and the lesion size (ß, 0.40; 95% CI, 0.31 to 0.50) after adjusting other covariates. The serum CrAg-LFA titers of 60 pulmonary cryptococcosis patients showed a decreasing trend with the reduction in pulmonary lesion size after effective therapy. CONCLUSION: In pulmonary cryptococcosis patients, the number and size of lung lesions are positively correlated with the titers of the serum CrAg-LFA test. The CrAg-LFA test could be a useful tool for the diagnosis, severity assessment, and therapeutic monitoring of localized pulmonary cryptococcosis patients.


Assuntos
Antígenos de Fungos , Criptococose , Pneumopatias Fúngicas , Tomografia Computadorizada por Raios X , Humanos , Masculino , Feminino , Estudos Retrospectivos , Pessoa de Meia-Idade , Antígenos de Fungos/sangue , Criptococose/diagnóstico por imagem , Criptococose/sangue , Pneumopatias Fúngicas/diagnóstico por imagem , Pneumopatias Fúngicas/sangue , Pneumopatias Fúngicas/imunologia , Adulto , Idoso , Pulmão/diagnóstico por imagem , Pulmão/patologia
2.
Infection ; 52(4): 1519-1525, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38652225

RESUMO

PURPOSE: Physicians may administer Nirmatrelvir-ritonavir to patients who have been symptomatic for more than 5 days. There is currently no clear evidence to support this approach. METHODS: A real-world study was conducted to investigate the potential relationship between the administration of Nirmatrelvir-ritonavir and the rates of intubation or in-hospital mortality among COVID-19 patients who experienced symptoms for more than 5 days. The end point was a composite event of intubation or in-hospital mortality. The outcomes between those patients who received Nirmatrelvir-ritonavir and those who did not were compared. RESULTS: A total of 847 patients were included in the analysis. Among them, 312 patients (36.84%) received Nirmatrelvir-ritonavir. Within the entire population, 86 patients (10.15%) experienced intubation or in-hospital mortality. The main analysis indicated that there was a significant association between the application of Nirmatrelvir-ritonavir and intubation or in-hospital mortality, with an odds ratio of 0.50 (95% confidence interval, 0.28 to 0.87; P = 0.0153) using inverse probability of treatment weighting. The finding was consistent with multiple sensitivity analyses. CONCLUSIONS: The application of Nirmatrelvir-ritonavir was associated with a significantly reduced risk of intubation or death in hospitalized COVID-19 patients who experienced symptoms for more than 5 days as compared to those who did not receive the treatment.


Assuntos
Tratamento Farmacológico da COVID-19 , Mortalidade Hospitalar , Ritonavir , Humanos , Ritonavir/uso terapêutico , Feminino , Masculino , Pessoa de Meia-Idade , Idoso , SARS-CoV-2 , Antivirais/uso terapêutico , COVID-19/mortalidade , Hospitalização/estatística & dados numéricos , Resultado do Tratamento , Quimioterapia Combinada , Estudos Retrospectivos
3.
Materials (Basel) ; 15(24)2022 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-36556578

RESUMO

Calcium carbonate, as the main inorganic component of human bones and teeth, has good biocompatibility and bioactivity and finds increasing applications in the field of bone drug carriers. In this study, hollow calcium carbonate microspheres were synthesized by a water hydrothermal method using folic acid as a template. Before drug loading, the prepared calcium carbonate microspheres were subjected to aminidation, carboxylation, and vinylenimine modification. The hollow calcium carbonate microspheres loaded with doxorubicin hydrochloride (DOX) were further incorporated with light-emitting carbon quantum dots(CQDs) and hyaluronic acid (HA). The result showed that the drug loading capacity in the as-prepared calcium carbonate was 179.064 mg/g. In the simulated solutions of cellular metabolism containing various concentrations of reduced glutathione(GSH), the sustained release of DOX was confirmed qualitatively by the luminescence of the CQDs. The DOX release rate was measured quantitively by UV absorption spectra. The highest release rate reached 85.99% in a simulated solution of 0.005 mol/L GSH solution, and the release rate could vary intelligently with the concentration.

4.
ACS Omega ; 6(27): 17217-17227, 2021 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-34278108

RESUMO

BACKGROUND AND PURPOSE: HOX transcript antisense RNA (HOTAIR) is a long noncoding RNA (lncRNA) that promotes tumor growth and metastasis. Exosomes can mediate intracellular communication in cancer by transferring active molecules. However, the role and mechanism of HOTAIR in nonsmall cell lung cancer (NSCLC) are still unclear. This study mainly explores the role and mechanism of exosome-derived HOTAIR in NSCLC. METHODS: after the material characterization of the CD63 immune lipid magnetic bead (CD63-IMB), the exosomes in serum of NSCLC patients were captured through CD63-IMB for the corresponding biological characterization. Real-time quantitative reverse transcription PCR (qRT-PCR) was performed to detect the expression level of HOTAIR in tumor tissues, serum, and serum exosome from NSCLC patients. Subsequently, exosome secreted by NCI-H1975 cells with highly expressed HOTAIR was selected to treat low-expression A549 cells and HOTAIR knockdown on NCI-H1975 cells. In this way, action mechanisms of HOTAIR can be investigated by means of qRT-PCR, colony formation assays, and flow cytometry. RESULTS: exosomes can be isolated by CD63-IMB, and taken up by cells effectively; the qRT-PCR results demonstrate that HOTAIR expressions are significantly upregulated in tumor tissues, serums, and exosomes isolated from serums of NSCLC patients. Clinicopathological correlation analysis shows that the upregulation of HOTAIR is closely associated with lymphatic metastasis and tumor node metastasis (TNM) staging (P < 0.05). HOTAIR expressions show a significant increase in A549 cells treated with exosomes derived from NCI-H1975 cells, signifying that both proliferation and migration of A549 cells are promoted, and HOTAIR depletion could inhibit the proliferation and migration of lung cancer cells. CONCLUSIONS: HOTAIR is highly expressed in tumor tissues, serums, and serum exosomes of NSCLC patients and its expression has a significant correlation with lymphatic metastasis and TNM staging. Moreover, the exosome may promote NSCLC proliferation and migration through HOTAIR transportation. Therefore, exosome-derived HOTAIR is expected to be a new molecular marker for NSCLC diagnosis, and exosomal transmission of HOTAIR may provide a new approach to NSCLC diagnosis.

5.
RSC Adv ; 9(30): 17281-17290, 2019 May 29.
Artigo em Inglês | MEDLINE | ID: mdl-35519893

RESUMO

A new adamantane-based ionic liquid, (11-(((-adamantane-1-carbonyl)oxy)undecyl)-1-methylimidazol-3-ium bromide (AD-C11im), was synthesized from 1-adamantanecarboxylic acid and observed that it can aggregate into micelles in aqueous solution. A number of experiments were conducted to understand the self-assembly of supra-amphiphiles building block fabricated by ß-cyclodextrin (ß-CD) and adamantane-based ionic liquid at diverse molar ratios. Studies revealed that host-guest interaction between the adamantane group and ß-CD occurred and AD-C11im@1ß-CD building block formed when same amount ß-CD was added. Then the micelles aggregates formed by AD-C11im only turned into spherical vesicles, which was confirmed by AFM, DLS and TEM. Besides, according to the results of AFM, it can be confirmed that the vesicles were monolayer structure. When double amount ß-CD was added, both the adamantane group and the hydrophobic chain were encapsulated by ß-CD and AD-C11im@2ß-CD building block formed. Thus the aggregations changed from vesicles to net-like nanofiber, which was observed by TEM. When the ß-CD concentration increased to 40 mM, the formation of light blue hydrogel was observed during the self-assembling process of AD-C11im@2ß-CD building block.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA